U.S. Court of Appeals for the Federal Circuit
Indivior Inc. v. Dr. Reddy's Laboratories, S.A.
This writing
- Type
- Opinion of the Court
- Filed
- July 12, 2019
- Case
- Indivior Inc. v. Dr. Reddy's Laboratories, S.A.
- Case status
- Decided
Source No authoring judge could be established for this writing, either from provider metadata or from the signature line of the court's published opinion. Benchlight shows the gap rather than guessing at an author.
Opening text
The first passage of the document, as extracted by the source provider.
Dissenting opinion filed by Circuit Judge Mayer. Lourie, Circuit Judge. *1330Dr. Reddy's Laboratories, S.A. and Dr. Reddy's Laboratories Inc. (collectively, "DRL"); Watson Laboratories Inc. and Actavis Laboratories UT, Inc. (collectively, "Watson"); and Teva Pharmaceuticals USA, Inc. ("Teva") appeal from several decisions…
Source Extract supplied by CourtListener. Benchlight does not host the document — read the authoritative text in the court's own PDF.